Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Lipocine Inc. (LPCN)

Fractyl Health, Inc. and Lipocine Inc. are both Biotechnology companies. Fractyl Health, Inc. and Lipocine Inc. are of similar size ($12.6M and $11.9M). Lipocine Inc. grew revenue faster over the last twelve months: −13.4% against −22.5%. Fractyl Health, Inc. has the higher net margin (0.00% vs −249.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Fractyl Health, Inc. leads on 9 and Lipocine Inc. on 7.

Valuation

Metric GUTS LPCN Biotechnology median
P/E n/m n/m 10.60
P/S 133.58 3.46 9.40
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 0.54 0.66
EV/Sales (45.93) (1.49) 9.02
Earnings yield (1,123.85%) (86.62%) (32.88%)
Free cash flow yield (668.02%) (78.12%) (23.13%)

Profitability

Metric GUTS LPCN Biotechnology median
Gross margin 46.24% 100.00% 68.51%
Operating margin 0.00% (269.05%) 0.00%
Net margin 0.00% (249.16%) 0.00%
Free cash flow margin 0.00% (267.37%) 0.00%
Return on equity 1,063.04% (52.86%) (51.96%)
Return on assets (146.75%) (47.52%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS LPCN Biotechnology median
Revenue growth (TTM) (22.50%) (13.36%) 6.76%
EPS growth (last fiscal year) (14.81%) (93,988.89%) 29.88%
Revenue growth, 5-year CAGR — 64.32% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS LPCN Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 11.36 4.97
Net debt to EBITDA 0.53 1.42 1.01

Dividend

Metric GUTS LPCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS LPCN Biotechnology median
Market cap 11.88m 12.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack